ArticleBMC cancer2024

A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial.

Divyalakshmi Bhaskaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.